PRTN3 and peeling skin syndrome: Previous studies showed that patients with pSS with joint symptoms had RF more often than those without joint symptoms (45% vs. 33%), and 5–10% of pSS patients were positive for anti-citrullinated peptide antibody (ACPA) [24,25].